|
[1]
|
Apostolaki M, Armaka M, Victoratos P,et al.Cellular mechanisms of TNF function in models of inflammation and autoimmunity[J].Curr Dir Autoimmun, 2010,11(2):1-26. |
|
[2]
|
Mukai Y,Nakamura T, Yoshikawa M,et al. Solution of the structure of the TNF-TNFR2 complex[J]. Sci Signal,2010,3 (148): 1-10. |
|
[3]
|
Hehlgans T, Pfeffer K. The intriguing biology of the tumounecrosis factor/tumour necrosis factor receptor superfamily players,rules and the games[J].Immunology,2005,115(1):1-20. |
|
[4]
|
Mcllwain DR,Lang PA,Maretzky T,et al.IRhom2 regulation of TACE controls TNF-mediated protection against listeria and responses to LPS[J].Science,2012,335(6065):229-232. |
|
[5]
|
Chen X, Wu X, Zhou Q,et al.TNFR2 is critical for the stabilization of the CD4+Foxp3+ Regulatory T cell phenotype in the inflammatory environmentl[J]. J Immuno,2013, 190(3):1076-1084. |
|
[6]
|
Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases[J].Nat Rev Drug Discov, 2010, 9(6):482-493. |
|
[7]
|
Magis C, van der Sloot AM, Serrano L,et al. An improved understanding of TNFL/TNFR interactions using structure-based classi cations[J].Trends Biochem Sci,2012,37(9):353-363. |
|
[8]
|
Dixon,Hyrich KL, Watson KD,et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)[J]. Ann Rheum Dis,2010,69(3):522-528. |
|
[9]
|
Takeuchi T, Tatsuki Y, NogamiY,et al. Post marketing surveillance of the safety profile of infliximab in 5 000 Japanese patients with rheumatoid arthritis[J].Ann Rheum Dis,2008, 67(2):189-194. |
|
[10]
|
Tang W, Lu Y, Tian QY,et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice[J]. Science, 2011, 332(6028): 478-484. |
|
[11]
|
Deng GM, Zheng LX,Lenardo M,et al. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors[J].Nat Med,2005,10(11):1066-1072. |
|
[12]
|
Hwang JR, Huh JH, Lee Y,et al. Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits TNF-a-induced NF-κB activity by binding to TNFR1[J]. Biochem Biophys Res Commun, 2011,405(4): 545-551. |
|
[13]
|
Mukai Y, Shibata H, Nakamura T,et al. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant[J].J Mol Biol, 2009, 385(4):1221-1229. |
|
[14]
|
Takasaki W,KajinoY,KajinoK,et al.Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF-αbinding to its receptor[J]. Nat Biotechnol, 1997, 15:1266-1270. |
|
[15]
|
Mukaro. Selective activation of tumour necrosis factor receptor-mediated intacellular signalling pathways[D].Adelaide: School of Paediatrics and Reproductive Health,2009. |
|
[16]
|
Chidnos-Rojas CL,Steward MW,PartidosCD,et al.Apeptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library[J]. J Immunol,1998,161(10):5621-5626. |
|
[17]
|
尹丙姣,黄丽霞,梁慧芳,等.TNFR1封闭肽-hIgGFc融合蛋白和TNFR1封闭肽对TNF-α介导的生物学效应的封闭作用[J].中国免疫学杂志,2008,24(9):776-780. |
|
[18]
|
Liang H, Yin B, Zhang H,et al. Blockade of tumor necrosis factor (TNF) receptor type1-mediated TNF-α signaling protected wistarrats from diet-Induced obesity and insulin resistance[J]. Endocrinology, 2008, 149(6):2943-2951. |
|
[19]
|
Roland E,Sabine M,Jens N,et al. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF)action[J].J Immunother,2008,31(3):225-234. |
|
[20]
|
Carter PH, Scherle PA, Muckelbauer JK,et al. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-a[J]. PNAS, 2001,98(21):11879-11884. |
|
[21]
|
Murali R, Cheng X, Berezov A,et al. Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107[J]. PNAS,2005,102(31):10970-10975. |
点击查看大图
下载:
